Jiangjiang Li

642 total citations
10 papers, 198 citations indexed

About

Jiangjiang Li is a scholar working on Cancer Research, Molecular Biology and Genetics. According to data from OpenAlex, Jiangjiang Li has authored 10 papers receiving a total of 198 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 4 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Jiangjiang Li's work include Cancer, Hypoxia, and Metabolism (5 papers), RNA modifications and cancer (3 papers) and Glioma Diagnosis and Treatment (3 papers). Jiangjiang Li is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), RNA modifications and cancer (3 papers) and Glioma Diagnosis and Treatment (3 papers). Jiangjiang Li collaborates with scholars based in China and United States. Jiangjiang Li's co-authors include Peng Huang, Wenhua Lu, Shijun Wen, Shuang Qiao, Christophe Glorieux, Ya Cao, Min Tang, Jian Zhou, Jia Fan and Ann M. Bode and has published in prestigious journals such as Nature Communications, Oncogene and Cancer Letters.

In The Last Decade

Jiangjiang Li

9 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiangjiang Li China	7	106	80	56	32	22	10	198
Liming Lin China	6	99 0.9×	62 0.8×	40 0.7×	29 0.9×	15 0.7×	8	194
Eva Hulstaert Belgium	8	118 1.1×	96 1.2×	74 1.3×	48 1.5×	14 0.6×	20	251
Taro Miyagawa Japan	8	135 1.3×	50 0.6×	39 0.7×	22 0.7×	13 0.6×	21	234
Lupin Jiang China	8	195 1.8×	83 1.0×	80 1.4×	33 1.0×	45 2.0×	12	352
Liyuan Qian China	5	192 1.8×	165 2.1×	57 1.0×	32 1.0×	24 1.1×	9	267
Tobias Gutting Germany	10	90 0.8×	55 0.7×	91 1.6×	36 1.1×	13 0.6×	18	219
Lucilla Fabbri France	8	230 2.2×	58 0.7×	28 0.5×	23 0.7×	16 0.7×	13	297
Xian-Long Fang China	8	210 2.0×	132 1.6×	58 1.0×	46 1.4×	15 0.7×	13	290
Pooja Shah United States	7	161 1.5×	58 0.7×	74 1.3×	11 0.3×	34 1.5×	17	227
Zhongxia Wang China	9	174 1.6×	55 0.7×	46 0.8×	29 0.9×	42 1.9×	21	304

Countries citing papers authored by Jiangjiang Li

Since Specialization

Citations

This map shows the geographic impact of Jiangjiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangjiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangjiang Li more than expected).

Fields of papers citing papers by Jiangjiang Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangjiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangjiang Li. The network helps show where Jiangjiang Li may publish in the future.

Co-authorship network of co-authors of Jiangjiang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangjiang Li. A scholar is included among the top collaborators of Jiangjiang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangjiang Li. Jiangjiang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Li, Jiangjiang, et al.. (2025). Targeting IDH2 promotes antitumor immunity through epigenetic activation of cGAS-STING pathway. Lung Cancer. 205. 108611–108611.

2.

Li, Jiangjiang, Jingyu Tian, Panpan Liu, et al.. (2024). Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature Communications. 15(1). 3445–3445. 16 indexed citations

3.

Li, He, Jiangjiang Li, Wenhua Lu, et al.. (2023). Targeting Mitochondrial IDH2 Enhances Antitumor Activity of Cisplatin in Lung Cancer via ROS-Mediated Mechanism. Biomedicines. 11(2). 475–475. 6 indexed citations

4.

Lei, Guanghua, Chao Zeng, Tubao Yang, et al.. (2022). A Cross-Sectional Study of Association between Plasma Selenium Levels and the Prevalence of Osteoarthritis: Data from the Xiangya Osteoarthritis Study. The journal of nutrition health & aging. 26(2). 197–202. 9 indexed citations

5.

Lu, Wenhua, Jingyu Tian, Shuang Qiao, et al.. (2022). Reductive TCA cycle catalyzed by wild-type IDH2 promotes acute myeloid leukemia and is a metabolic vulnerability for potential targeted therapy. Journal of Hematology & Oncology. 15(1). 30–30. 31 indexed citations

6.

Qiao, Shuang, Wenhua Lu, Christophe Glorieux, et al.. (2021). Wild-type IDH2 protects nuclear DNA from oxidative damage and is a potential therapeutic target in colorectal cancer. Oncogene. 40(39). 5880–5892. 23 indexed citations

7.

Shi, Feng, Jiangjiang Li, Min Tang, et al.. (2020). Wild-type IDH2 contributes to Epstein–Barr virus-dependent metabolic alterations and tumorigenesis. Molecular Metabolism. 36. 100966–100966. 23 indexed citations

8.

Lu, Jingchen, Min Tang, Hongde Li, et al.. (2016). EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma. Cancer Letters. 380(1). 191–200. 76 indexed citations

9.

Li, Jiangjiang, Jingchen Lu, Yong Wu, et al.. (2016). A new functional IDH2 genetic variant is associated with the risk of lung cancer. Molecular Carcinogenesis. 56(3). 1082–1087. 5 indexed citations

10.

Yang, Yu, Xiang Wang, Jiafu Shi, & Jiangjiang Li. (2011). The influence of the discharging sewage on microbial diversity in sludge from Dongting Lake. World Journal of Microbiology and Biotechnology. 28(2). 421–430. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact